Hutchmed/$HCM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Hutchmed
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Ticker
$HCM
Sector
Primary listing
Employees
1,796
Headquarters
Hong Kong, Hong Kong
Website
Hutchmed Metrics
BasicAdvanced
$1.8bn
19.77
$0.52
0.38
-
Price and volume
Market cap
$1.8bn
Beta
0.38
52-week high
$19.50
52-week low
$10.01
Average daily volume
53k
Financial strength
Current ratio
4.963
Quick ratio
4.807
Long term debt to equity
5.598
Total debt to equity
7.824
Interest coverage (TTM)
-13.67%
Profitability
EBITDA (TTM)
-25.852
Gross margin (TTM)
11.64%
Net profit margin (TTM)
83.30%
Operating margin (TTM)
-7.14%
Effective tax rate (TTM)
12.20%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
-1.62%
Return on equity (TTM)
45.25%
Valuation
Price to earnings (TTM)
19.769
Price to revenue (TTM)
16.085
Price to book
1.1
Price to tangible book (TTM)
1.1
Price to free cash flow (TTM)
-99.354
Free cash flow yield (TTM)
-1.01%
Free cash flow per share (TTM)
-0.103
Growth
Revenue change (TTM)
-12.96%
Earnings per share change (TTM)
1,200.03%
3-year revenue growth (CAGR)
8.76%
10-year revenue growth (CAGR)
11.90%
3-year earnings per share growth (CAGR)
6.54%
10-year earnings per share growth (CAGR)
23.30%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs